The U.S. Food and Drug Administration approved a prefilled syringe for self-injection of the allergic diseases treatment Xolair developed by Novartis and Genentech, a Roche company.
Swiss drugmakers Roche and Novartis each won European approval for drugs on March 30 in a sign that the rival Basel-based companies are increasingly competing for the same patients.
Roche is calling it quits on a late-stage trial of the company’s Huntington’s disease hopeful tominersen, the Swiss drugmaker said on March 22, a blow for sufferers of the rare, debilitating disease with no treatments to stop or reverse it.
Roche’s checkpoint inhibitor Tecentriq (atezolizumab) hit the mark in the company’s Phase III IMpower010 trial of the drug compared to best supportive care (BSC) in people with resectable early-stage lung cancer.
Roche is launching a SARS-CoV-2 variant test to help monitor emerging coronavirus mutations, the Swiss pharmaceuticals group said on March 16.
Shares of GenMark Diagnostics soared in trading on March 15 after Roche announced the acquisition of the California-based company in a $1.8 billion deal to bolster the Swiss pharma giant’s diagnostics pipeline.
Swiss drugmaker Roche said on March 11 adding the company’s drug Actemra to Gilead Sciences’ Veklury medication, also called remdesivir, did not reduce hospital stays for patients with severe Covid-19 pneumonia.
Two weeks after AstraZeneca announced the company was withdrawing the use of Imfinzi as a treatment for bladder cancer in the United States, Swiss pharma giant Roche followed suit with the checkpoint inhibitor Tecentriq (atezolizumab).
Roche’s arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe Covid-19, also shortening the time to recovery and reducing the need for mechanical ventilation, results of a large trial showed.
Larger clinical trials are needed to assess whether Roche’s Actemra (tocilizumab) can cut death rates among the sickest Covid-19 patients after a small study found the arthritis drug was no better than standard care in severe cases.